225 related articles for article (PubMed ID: 11562779)
1. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
Odunsi K; Ganesan T
Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
[TBL] [Abstract][Full Text] [Related]
2. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HLA-DRB1*0901-binding HPV-16 E7 helper T cell epitope.
Okubo M; Saito M; Inoku H; Hirata R; Yanagisawa M; Takeda S; Kinoshita K; Maeda H
J Obstet Gynaecol Res; 2004 Apr; 30(2):120-9. PubMed ID: 15009616
[TBL] [Abstract][Full Text] [Related]
4. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
5. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ.
Beskow AH; Josefsson AM; Gyllensten UB
Int J Cancer; 2001 Sep; 93(6):817-22. PubMed ID: 11519043
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
7. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
[TBL] [Abstract][Full Text] [Related]
8. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.
Odunsi K; Terry G; Ho L; Bell J; Cuzick J; Ganesan TS
Int J Cancer; 1996 Sep; 67(5):595-602. PubMed ID: 8782644
[TBL] [Abstract][Full Text] [Related]
10. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
[TBL] [Abstract][Full Text] [Related]
11. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
Beskow AH; Gyllensten UB
Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
[TBL] [Abstract][Full Text] [Related]
12. HLA Class II genotypes associated with early-onset periodontitis: DQB1 molecule primarily confers susceptibility to the disease.
Ohyama H; Takashiba S; Oyaizu K; Nagai A; Naruse T; Inoko H; Kurihara H; Murayama Y
J Periodontol; 1996 Sep; 67(9):888-94. PubMed ID: 8884646
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
14. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.
Cuzick J; Terry G; Ho L; Monaghan J; Lopes A; Clarkson P; Duncan I
Br J Cancer; 2000 Apr; 82(7):1348-52. PubMed ID: 10755413
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
Laivoranta-Nyman S; Möttönen T; Hermann R; Tuokko J; Luukkainen R; Hakala M; Hannonen P; Korpela M; Yli-Kerttula U; Toivanen A; Ilonen J;
Ann Rheum Dis; 2004 Nov; 63(11):1406-12. PubMed ID: 15479890
[TBL] [Abstract][Full Text] [Related]
16. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
